Searched for
ALKEM LAB
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...- Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsMarkets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,...
- Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAlkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stocks in news: Infosys, Trent, Jio Financial, Hindustan Copper, Adani EnergyMarkets experienced a corrective session, with Nifty expected to consolidate but maintain a positive bias. Key stocks like Infosys, Trent, ...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- Obesity bet may drive focus on chronic segment: Alkem LabsAlkem Labs anticipates its upcoming semaglutide launch will drive a strategic shift from acute treatments to chronic care, including diabet...
- Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 croreThe company reported Rs 287 crore in the corresponding quarter of the previous year. Revenue from operations grew 2.2% y-o-y to Rs 3032 cro...
- Alkem Labs plunges more than 13%, sees biggest single-day fall in over 3 years on tax evasion allegationIn September last year, the tax department conducted surveys on the offices and premises of the company after receiving intelligence regard...
- Buy Alkem Lab, target price Rs 3,300: Angel BrokingThe pharma company is expected to outperform the Indian Pharmaceutical market (IPM) by 1.5 times growth rate for the next 2 years.
- Stock pick of the week: What makes Alkem Lab a good long term buyAlkem Lab is reasonably priced compared to its competitors and the recent correction has offered a good opportunity to long-term investors.
- Alkem stock up 5% as its Gujarat unit gets USFDA nodShares of Alkem Labs today went up by over 5 per cent after the company said one of its manufacturing plants in Gujarat has obtained establ...
- Alkem's Mandva plant gets establishment nod from USFDAAlkem Labs Ltd today said one of its manufacturing plants in Gujarat has obtained the Establishment Inspection Report (EIR) "approval" from...
- Alkem Labs, Dr Lal PathLabs listings to help drive expansionAlkem Labs and Dr Lal PathLabs made an impressive start at the bourses on Wednesday, opening 31 per cent and 50 per cent higher from their ...
- Alkem Labs will continue to outperform the industry in next 18 months: Sandeep Singh, Director"I can't share any numbers at this point. But I can tell you that H1 was very nice, much better than last year. We expect this year to be a...
- Strong growth and fair valuation make Alkem Labs a good betMumbaibased Alkem Labs is the local market leader in anti-infectives. It earns three-fourths of its revenues from India – a significant por...
- Pharmaceutical company Alkem Laboratories eyeing big-bang IPO in FY-1580% of the company's revenues currently come from domestic operations and now it's main focus is on the US market.
Load More
